{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:10:12Z","timestamp":1760299812783},"reference-count":84,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.cpet.2017.11.006","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T22:35:52Z","timestamp":1519425352000},"page":"203-223","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["FDG-PET Assessment of Other Gynecologic Cancers"],"prefix":"10.1016","volume":"13","author":[{"given":"Silvana","family":"Faria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Devine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chitra","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaz","family":"Javadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brinda Rao","family":"Korivi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya R.","family":"Bhosale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.cpet.2017.11.006_bib1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/OGX.0000000000000345","article-title":"Positron emission tomography\/computed tomography for gynecologic malignancies","volume":"71","author":"Oldan","year":"2016","journal-title":"Obstet Gynecol Surv"},{"issue":"4","key":"10.1016\/j.cpet.2017.11.006_bib2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cpet.2010.07.005","article-title":"PET\/CT imaging in gynecologic malignancies other than ovarian and cervical cancer","volume":"5","author":"Bhosale","year":"2010","journal-title":"PET Clin"},{"issue":"2","key":"10.1016\/j.cpet.2017.11.006_bib3","first-page":"266","article-title":"Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET\/CT","volume":"45","author":"Lerman","year":"2004","journal-title":"J\u00a0Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2017.11.006_bib4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ygyno.2005.04.027","article-title":"Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer","volume":"98","author":"Amant","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.006_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.006_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bpobgyn.2011.12.007","article-title":"Endometrial cancer","volume":"26","author":"Arora","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.006_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.cpet.2017.11.006_bib8","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1016\/S1470-2045(13)70591-6","article-title":"Classification of endometrial carcinoma: more than two types","volume":"15","author":"Murali","year":"2014","journal-title":"Lancet Oncol"},{"issue":"2 Pt 1","key":"10.1016\/j.cpet.2017.11.006_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/AOG.0b013e3182605bf1","article-title":"Endometrial cancer","volume":"120","author":"Sorosky","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"Suppl 2","key":"10.1016\/j.cpet.2017.11.006_bib10","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.ijgo.2015.06.005","article-title":"Cancer of the corpus uteri","volume":"131","author":"Amant","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.cpet.2017.11.006_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4103\/0971-3026.155857","article-title":"Imaging in endometrial carcinoma","volume":"25","author":"Faria","year":"2015","journal-title":"Indian J Radiol Imaging"},{"issue":"4","key":"10.1016\/j.cpet.2017.11.006_bib12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.crad.2010.07.012","article-title":"Established, emerging and future applications of FDG-PET\/CT in the uterine cancer","volume":"66","author":"Kitajima","year":"2011","journal-title":"Clin Radiol"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.006_bib13","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2214\/AJR.09.4074","article-title":"Spectrum of FDG PET\/CT findings of uterine tumors","volume":"195","author":"Kitajima","year":"2010","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.cpet.2017.11.006_bib14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.rcl.2013.07.006","article-title":"Positron emission tomography-computed tomography imaging for malignancies in women","volume":"51","author":"Viswanathan","year":"2013","journal-title":"Radiol Clin North Am"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.006_bib15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ygyno.2007.11.044","article-title":"Comparison of the validity of magnetic resonance imaging and positron emission tomography\/computed tomography in the preoperative evaluation of patients with uterine corpus cancer","volume":"108","author":"Park","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.cpet.2017.11.006_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4329\/wjr.v4.i5.207","article-title":"Comparison of DWI and PET\/CT in evaluation of lymph node metastasis in uterine cancer","volume":"4","author":"Kitajima","year":"2012","journal-title":"World J Radiol"},{"issue":"6","key":"10.1016\/j.cpet.2017.11.006_bib17","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00330-008-1271-8","article-title":"Accuracy of integrated FDG-PET\/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer","volume":"19","author":"Kitajima","year":"2009","journal-title":"Eur Radiol"},{"issue":"11","key":"10.1016\/j.cpet.2017.11.006_bib18","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.ejrad.2012.01.024","article-title":"18F-FDG PET or PET\/CT for detection of metastatic lymph nodes in patients with endometrial cancer: a systematic review and meta-analysis","volume":"81","author":"Chang","year":"2012","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.006_bib19","first-page":"20","article-title":"18F-FDG PET\/CT and sentinel lymph node biopsy in the staging of patients with cervical and endometrial cancer. Role of dual-time-point imaging","volume":"36","author":"Mayoral","year":"2017","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"issue":"2","key":"10.1016\/j.cpet.2017.11.006_bib20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1148\/radiol.2016160200","article-title":"Utility of PET\/CT to evaluate retroperitoneal lymph node metastasis in high-risk endometrial cancer: results of ACRIN 6671\/GOG 0233 trial","volume":"283","author":"Atri","year":"2017","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.cpet.2017.11.006_bib21","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2967\/jnumed.115.170597","article-title":"High diagnostic value of 18F-FDG PET\/CT in endometrial cancer: systematic review and meta-analysis of the literature","volume":"57","author":"Bollineni","year":"2016","journal-title":"J\u00a0Nucl Med"},{"issue":"7","key":"10.1016\/j.cpet.2017.11.006_bib22","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/IGC.0000000000000773","article-title":"The combination of preoperative fluorodeoxyglucose positron emission tomography\/computed tomography and sentinel lymph node mapping in the surgical management of endometrioid endometrial cancer","volume":"26","author":"Bese","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"10.1016\/j.cpet.2017.11.006_bib23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.5603\/GP.2016.0032","article-title":"Prognostic value of 18F-FDG PET\/CT for identifying high- and low-risk endometrial cancer patients","volume":"87","author":"Ozgu","year":"2016","journal-title":"Ginekol Pol"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.006_bib24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ygyno.2014.01.039","article-title":"Risk stratification and prognosis determination using (18)F-FDG PET imaging in endometrial cancer patients: a systematic review and meta-analysis","volume":"132","author":"Ghooshkhanei","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.cpet.2017.11.006_bib25","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nrclinonc.2014.134","article-title":"Quantitative multimodality imaging in cancer research and therapy","volume":"11","author":"Yankeelov","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1016\/j.cpet.2017.11.006_bib26","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/MNM.0b013e328337cb47","article-title":"High-grade endometrial cancer: value of [(18)F]FDG PET\/CT in preoperative staging","volume":"31","author":"Picchio","year":"2010","journal-title":"Nucl Med Commun"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.006_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.crad.2006.06.015","article-title":"Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis","volume":"62","author":"Sohaib","year":"2007","journal-title":"Clin Radiol"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.006_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF02990022","article-title":"Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer","volume":"17","author":"Saga","year":"2003","journal-title":"Ann Nucl Med"},{"issue":"9823","key":"10.1016\/j.cpet.2017.11.006_bib29","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(12)60442-5","article-title":"Contemporary management of endometrial cancer","volume":"379","author":"Wright","year":"2012","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.cpet.2017.11.006_bib30","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1007\/s00259-002-0878-2","article-title":"Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma","volume":"29","author":"Belhocine","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.006_bib31","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00259-008-0956-1","article-title":"Performance of integrated FDG-PET\/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT","volume":"36","author":"Kitajima","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.cpet.2017.11.006_bib32","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00259-007-0687-8","article-title":"The clinical impact of [(18)F]FDG PET\/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings","volume":"35","author":"Chung","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.cpet.2017.11.006_bib33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.tranon.2017.01.002","article-title":"Prediction of recurrence by preoperative intratumoral FDG uptake heterogeneity in endometrioid endometrial cancer","volume":"10","author":"Kang","year":"2017","journal-title":"Transl Oncol"},{"issue":"8","key":"10.1016\/j.cpet.2017.11.006_bib34","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2967\/jnumed.115.159913","article-title":"Metabolic tumor volume on 18F-FDG PET\/CT improves preoperative identification of high-risk endometrial carcinoma patients","volume":"56","author":"Husby","year":"2015","journal-title":"J\u00a0Nucl Med"},{"issue":"9","key":"10.1016\/j.cpet.2017.11.006_bib35","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/1471-0528.12543","article-title":"Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET\/CT, predict the recurrence of endometrial cancer","volume":"121","author":"Shim","year":"2014","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.cpet.2017.11.006_bib36","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ijrobp.2005.02.004","article-title":"Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer","volume":"63","author":"Lin","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.006_bib37","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2967\/jnumed.114.145011","article-title":"Evaluation of gynecologic cancer with MR imaging, 18F-FDG PET\/CT, and PET\/MR imaging","volume":"56","author":"Lee","year":"2015","journal-title":"J\u00a0Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.006_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12149-013-0777-6","article-title":"Value of fusion of PET and MRI in the detection of intra-pelvic recurrence of gynecological tumor: comparison with 18F-FDG contrast-enhanced PET\/CT and pelvic MRI","volume":"28","author":"Kitajima","year":"2014","journal-title":"Ann Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.006_bib39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00259-014-2902-8","article-title":"[(18)F]FDG PET\/MRI vs. PET\/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results","volume":"42","author":"Beiderwellen","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.cpet.2017.11.006_bib40","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.ejrad.2015.08.010","article-title":"Implementation of FAST-PET\/MRI for whole-body staging of female patients with recurrent pelvic malignancies: a comparison to PET\/CT","volume":"84","author":"Grueneisen","year":"2015","journal-title":"Eur J Radiol"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.006_bib41","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.mric.2017.03.012","article-title":"PET\/MR imaging in gynecologic oncology","volume":"25","author":"Ohliger","year":"2017","journal-title":"Magn Reson Imaging Clin N Am"},{"issue":"5","key":"10.1016\/j.cpet.2017.11.006_bib42","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12149-017-1164-5","article-title":"Comparison of 18F-FDG-PET\/CT and 18F-FDG-PET\/MR imaging in oncology: a systematic review","volume":"31","author":"Singnurkar","year":"2017","journal-title":"Ann Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2017.11.006_bib43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/j.semnuclmed.2015.03.005","article-title":"PET\/MRI evaluation of gynecologic malignancies and prostate cancer","volume":"45","author":"Bagade","year":"2015","journal-title":"Semin Nucl Med"},{"issue":"6","key":"10.1016\/j.cpet.2017.11.006_bib44","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.clon.2008.04.002","article-title":"The management of uterine sarcomas","volume":"20","author":"Reed","year":"2008","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.006_bib45","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2017.02.019","article-title":"Uterine leiomyosarcoma: epidemiology, contemporary treatment strategies and the impact of uterine morcellation","volume":"145","author":"Ricci","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.cpet.2017.11.006_bib46","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.6004\/jnccn.2015.0162","article-title":"Uterine sarcoma, version 1.2016: featured updates to the NCCN guidelines","volume":"13","author":"Koh","year":"2015","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.006_bib47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","article-title":"Uterine sarcomas: a review","volume":"116","author":"D'Angelo","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.cpet.2017.11.006_bib48","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/j.ijgo.2015.06.006","article-title":"Uterine sarcomas","volume":"131","author":"Prat","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.006_bib49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijgo.2008.12.008","article-title":"FIGO staging for uterine sarcomas","volume":"104","author":"Prat","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"10.1016\/j.cpet.2017.11.006_bib50","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/cncr.23245","article-title":"Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy","volume":"112","author":"Kapp","year":"2008","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.cpet.2017.11.006_bib51","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1007\/s00261-017-1076-9","article-title":"Magnetic resonance imaging features of uterine sarcoma and mimickers","volume":"42","author":"Barral","year":"2017","journal-title":"Abdom Radiol (NY)"},{"issue":"4","key":"10.1016\/j.cpet.2017.11.006_bib52","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.tjog.2017.05.003","article-title":"Efficacy of PET\/CT to exclude leiomyoma in patients with lesions suspicious for uterine sarcoma on MRI","volume":"56","author":"Kusunoki","year":"2017","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.cpet.2017.11.006_bib53","first-page":"1069","article-title":"Use of 18F-fluorodeoxyglucose positron emission tomography for diagnosis of uterine sarcomas","volume":"23","author":"Nagamatsu","year":"2010","journal-title":"Oncol Rep"},{"issue":"10","key":"10.1016\/j.cpet.2017.11.006_bib54","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1007\/s00259-011-1851-8","article-title":"Additional value of 16alpha-[18F]fluoro-17beta-oestradiol PET for differential diagnosis between uterine sarcoma and leiomyoma in patients with positive or equivocal findings on [18F]fluorodeoxyglucose PET","volume":"38","author":"Yoshida","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.006_bib55","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.3802\/jgo.2017.28.e28","article-title":"Prognostic significance of preoperative (1)(8)F-FDG PET\/CT in uterine leiomyosarcoma","volume":"28","author":"Park","year":"2017","journal-title":"J\u00a0Gynecol Oncol"},{"issue":"14","key":"10.1016\/j.cpet.2017.11.006_bib56","doi-asserted-by":"crossref","first-page":"22581","DOI":"10.18632\/oncotarget.15127","article-title":"18F-FDG\/18F-FES standardized uptake value ratio determined using PET predicts prognosis in uterine sarcoma","volume":"8","author":"Yamamoto","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.cpet.2017.11.006_bib57","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/IGC.0000000000000936","article-title":"Surgery for recurrent uterine cancer: surgical outcomes and implications for survival-a case series","volume":"27","author":"Domenici","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"10.1016\/j.cpet.2017.11.006_bib58","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/IGC.0000000000000290","article-title":"Uterine leiomyosarcoma: a review article","volume":"24","author":"Gockley","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.006_bib59","first-page":"246","article-title":"Whole-body positron emission tomography with 18F-fluorodeoxyglucose is an effective method to detect extra-pelvic recurrence in uterine sarcomas","volume":"29","author":"Sung","year":"2008","journal-title":"Eur J Gynaecol Oncol"},{"issue":"2","key":"10.1016\/j.cpet.2017.11.006_bib60","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ygyno.2008.01.030","article-title":"Role of PET or PET\/CT in the post-therapy surveillance of uterine sarcoma","volume":"109","author":"Park","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.006_bib61","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.AOG.0000202404.55215.72","article-title":"Carcinoma of the vulva","volume":"107","author":"Stehman","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"Suppl 2","key":"10.1016\/j.cpet.2017.11.006_bib62","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/j.ijgo.2015.06.002","article-title":"Cancer of the vulva","volume":"131","author":"Hacker","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"issue":"8","key":"10.1016\/j.cpet.2017.11.006_bib63","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1097\/IGC.0000000000001075","article-title":"Sentinel lymph node biopsy in the management of vulvar carcinoma: an evidence-based insight","volume":"27","author":"Brincat","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.006_bib64","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/gyno.1993.1127","article-title":"Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study)","volume":"49","author":"Homesley","year":"1993","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.006_bib65","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/IGC.0b013e31823eed4c","article-title":"Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment","volume":"22","author":"Woelber","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.cpet.2017.11.006_bib66","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2214\/AJR.12.9714","article-title":"Multimodality imaging of vulvar cancer: staging, therapeutic response, and complications","volume":"200","author":"Viswanathan","year":"2013","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.006_bib67","first-page":"230","article-title":"Whole-body [18F]fluoro-2-deoxyglucose positron emission tomography scan as combined PET-CT staging prior to planned radical vulvectomy and inguinofemoral lymphadenectomy for squamous vulvar cancer: a correlation with groin node metastasis","volume":"35","author":"Kamran","year":"2014","journal-title":"Eur J Gynaecol Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2017.11.006_bib68","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/IGC.0b013e3181a13021","article-title":"Chemoradiation in advanced vulval carcinoma","volume":"19","author":"Rogers","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.cpet.2017.11.006_bib69","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00330-014-3530-1","article-title":"Computed tomography, magnetic resonance imaging and FDG positron emission tomography in the management of vulvar malignancies","volume":"25","author":"Lin","year":"2015","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.cpet.2017.11.006_bib70","first-page":"87","article-title":"Utility of the PET\/CT in vulvar cancer management","volume":"33","author":"Peir\u00f3","year":"2014","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"issue":"12","key":"10.1016\/j.cpet.2017.11.006_bib71","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.2967\/jnumed.117.194332","article-title":"Evaluation of dual time point imaging 18F-FDG PET\/CT for lymph node staging in vulvar cancer","volume":"58","author":"Collarino","year":"2017","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2017.11.006_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2016.07.007","article-title":"Risk factors and treatment for recurrent vulvar squamous cell carcinoma","volume":"106","author":"Nooij","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.006_bib73","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ygyno.2016.07.009","article-title":"Patterns of distant metastases in vulvar cancer","volume":"142","author":"Prieske","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.cpet.2017.11.006_bib74","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/(SICI)1097-0142(19980901)83:5<1033::AID-CNCR30>3.0.CO;2-6","article-title":"The national cancer data base report on cancer of the vagina","volume":"83","author":"Creasman","year":"1998","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.cpet.2017.11.006_bib75","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00001703-199408000-00012","article-title":"Pathology of the vulva and vagina","volume":"6","author":"Mullins","year":"1994","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"Suppl 2","key":"10.1016\/j.cpet.2017.11.006_bib76","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.ijgo.2015.06.003","article-title":"Cancer of the vagina","volume":"131","author":"Hacker","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"10.1016\/j.cpet.2017.11.006_bib77","doi-asserted-by":"crossref","first-page":"e65048","DOI":"10.1371\/journal.pone.0065048","article-title":"Concurrent chemoradiation for vaginal cancer","volume":"8","author":"Miyamoto","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.006_bib78","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijrobp.2004.09.032","article-title":"Definitive radiation therapy for squamous cell carcinoma of the vagina","volume":"62","author":"Frank","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.006_bib79","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ijrobp.2004.12.011","article-title":"FDG-PET evaluation of vaginal carcinoma","volume":"62","author":"Lamoreaux","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.006_bib80","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ygyno.2016.01.011","article-title":"The impact of FDG-PET\/CT in the management of patients with vulvar and vaginal cancer","volume":"140","author":"Robertson","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.006_bib81","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.critrevonc.2011.04.004","article-title":"Vaginal cancer","volume":"81","author":"Di Donato","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9","key":"10.1016\/j.cpet.2017.11.006_bib82","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1097\/IGC.0000000000000288","article-title":"Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer","volume":"24","author":"Sardain","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.006_bib83","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ygyno.2007.03.018","article-title":"A\u00a0prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration","volume":"106","author":"Husain","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"1052","key":"10.1016\/j.cpet.2017.11.006_bib84","doi-asserted-by":"crossref","first-page":"20150033","DOI":"10.1259\/bjr.20150033","article-title":"Primary vaginal cancer: role of MRI in diagnosis, staging and treatment","volume":"88","author":"Gardner","year":"2015","journal-title":"Br J Radiol"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859817301293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859817301293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T17:08:29Z","timestamp":1603904909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859817301293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1556859817301293"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2017.11.006","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FDG-PET Assessment of Other Gynecologic Cancers","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2017.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}